Right ventricular end‐diastolic volume and outcomes in exacerbations of COPD
Authors:
- Paul LeongPLPaul Leong
- Christian R. OsadnikCOChristian R. Osadnik
- Paul T. KingPKPaul T. King
- Martin I. MacDonaldMMMartin I. MacDonald
- Kenneth K. LauKLKenneth K. Lau
- Simon A. JoostenSJSimon A. Joosten
- Alexander ChuaACAlexander Chua
- Kais HamzaKHKais Hamza
- Ahilan KuganesanAKAhilan Kuganesan
- John M. TroupisJTJohn M. Troupis
- 25 October 2021
- journal article
- research article
- Published by Wiley in Respirology
- Vol. 27 (1) , 56-65
Abstract
Background and objective Right ventricular (RV) volumes are crucial outcome determinants in pulmonary diseases. Little is known about the associations of RV volumes during hospitalized acute exacerbations of chronic obstructive pulmonary disease (AECOPD). We aimed to ascertain associations of RV end-diastolic volume indexed to body surface area (RVEDVI) during hospitalized AECOPD and its relationship with mortality in long-term follow-up. Methods This is a prospective observational cohort study (December 2013–November 2019, ACTRN12617001562369) using dynamic retrospective ECG-gated computed tomography during hospitalized AECOPD. RVEDVI was defined as normal or high using Framingham Offspring Cohort values. Cox regression determined the prognostic relevance of RVEDVI for death. Results A total of 148 participants (70 ± 10 years [mean ± SD], 88 [59%] men) were included, of whom 75 (51%) had high RVEDVI. This was associated with more frequent hospital admissions in the 12 months before admission (52/75 [69%] vs. 38/73 [52%], p = 0.04) and higher breathlessness (modified Medical Research Council score, 2.9 ± 1.3 vs. 2.4 ± 1.2, p = 0.007). During follow-up, high RVEDVI was associated with greater mortality (log-rank p = 0.001). In univariable Cox regression, increasing RVEDVI was associated with higher mortality (hazard ratio [HR]: 1.02 per ml/m2; 95% CI: 1.01, 1.03; p = 0.001). In multivariable Cox regression, RVEDVI was independently associated with mortality (HR: 1.01 per ml/m2; 95% CI: 1.00, 1.03; p = 0.050) at a borderline significance level. Adding RVEDVI to three COPD mortality prediction systems improved model fit (pooled chi-square test [BODE: p = 0.05, ADO: p = 0.04, DOSE: p = 0.02]). Conclusion In patients with hospitalized AECOPD, higher RV end-diastolic volume was associated with worse acute clinical parameters and greater mortality.Keywords
Funding Information
- National Health and Medical Research Council (Postgraduate Scholarship)
- Royal Australasian College of Physicians (Dixon Award)
This publication has 29 references indexed in Scilit:
- The DECAF Score: predicting hospital mortality in exacerbations of chronic obstructive pulmonary diseaseThorax, 2012
- Comorbidities and Risk of Mortality in Patients with Chronic Obstructive Pulmonary DiseaseAmerican Journal of Respiratory and Critical Care Medicine, 2012
- Predictive properties of different multidimensional staging systems in patients with chronic obstructive pulmonary diseaseInternational Journal of Chronic Obstructive Pulmonary Disease, 2011
- Development and first validation of the COPD Assessment TestEuropean Respiratory Journal, 2009
- Assessment of Global Right Ventricular Function on 64-MDCT Compared with MRIAmerican Journal of Roentgenology, 2008
- Multi–detector row cardiac computed tomography accurately quantifies right and left ventricular size and function compared with cardiac magnetic resonanceAmerican Heart Journal, 2006
- Comparison of Computed Density and Microscopic Morphometry in Pulmonary EmphysemaAmerican Journal of Respiratory and Critical Care Medicine, 1996
- The Effects of Controlled Oxygen Therapy on Ventricular function in Patients with Stable and Decompensated Cor PulmonaleAmerican Review of Respiratory Disease, 1988
- The Hospital Anxiety and Depression ScaleActa Psychiatrica Scandinavica, 1983
- Factors Contributing to the Reversible Pulmonary Hypertension of Patients with Acute Respiratory Failure Studied by Serial Observations during RecoveryCirculation Research, 1969